LNAI — Lunai Bioworks Inc.
Lunai Bioworks Inc. (LNAI), formerly operating as Renovaro, is now dedicated to leveraging artificial intelligence for the creation of advanced medical treatments and the strengthening of biological defense systems. A significant project currently underway is the development of its specialized "Neurotoxicity Intelligence Technology."
Company profile
- Sector: Healthcare
- Industry: Biotechnology
- Country: US
- Exchange: NASDAQ Global Market
- Employees: 29
- Website: https://www.lunaibioworks.com
Latest SEC filings for LNAI
- S-8 POS — 2026-10-23
- POS AM — 2026-10-23
- S-8 POS — 2026-10-23
- NT 10-K — 2026-09-29
- 8-K — 2026-06-17
- 8-K — 2026-06-16
- 8-K — 2026-05-20
- 10-Q — 2026-05-15
- 8-K — 2026-05-13
- 8-K/A — 2026-05-11
Latest LNAI news
- — Lunai Bioworks plans Nasdaq delisting (seekingalpha_market)
Educational tool only — not investment advice.